Filing Details
- Accession Number:
- 0001035267-23-000105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-24 20:01:45
- Reporting Period:
- 2023-04-21
- Accepted Time:
- 2023-04-24 20:01:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1035267 | Intuitive Surgical Inc | ISRG | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 770416458 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1209186 | J Mark Rubash | 1020 Kifer Road Sunnyvale CA 94086 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-21 | 463 | $90.49 | 15,463 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-21 | 463 | $297.89 | 15,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-21 | 173 | $71.32 | 15,173 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-21 | 173 | $297.89 | 15,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-21 | 349 | $71.32 | 15,349 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-21 | 349 | $297.93 | 15,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-21 | 349 | $71.32 | 15,349 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-21 | 349 | $297.94 | 15,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-21 | 349 | $71.32 | 15,349 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-21 | 349 | $297.94 | 15,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 173 | $0.00 | 173 | $71.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 349 | $0.00 | 349 | $71.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 349 | $0.00 | 349 | $71.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 349 | $0.00 | 349 | $71.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 927 | $0.00 | 927 | $90.49 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 927 | $0.00 | 927 | $90.49 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 927 | $0.00 | 927 | $90.49 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 463 | $0.00 | 463 | $90.49 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 598 | $0.00 | 598 | $154.24 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 598 | $0.00 | 598 | $154.24 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 598 | $0.00 | 598 | $154.24 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 299 | $0.00 | 299 | $154.24 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 460 | $0.00 | 460 | $171.07 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 460 | $0.00 | 460 | $171.07 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 460 | $0.00 | 460 | $171.07 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 230 | $0.00 | 230 | $171.07 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 472 | $0.00 | 472 | $172.59 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 472 | $0.00 | 472 | $172.59 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 472 | $0.00 | 472 | $172.59 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-21 | 235 | $0.00 | 235 | $172.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,570 | 2026-04-21 | No | 4 | M | Direct | |
| 1,221 | 2026-04-21 | No | 4 | M | Direct | |
| 872 | 2026-04-21 | No | 4 | M | Direct | |
| 523 | 2026-04-21 | No | 4 | M | Direct | |
| 3,708 | 2027-04-20 | No | 4 | M | Direct | |
| 2,781 | 2027-04-20 | No | 4 | M | Direct | |
| 1,854 | 2027-04-20 | No | 4 | M | Direct | |
| 1,391 | 2027-04-20 | No | 4 | M | Direct | |
| 2,390 | 2028-04-19 | No | 4 | M | Direct | |
| 1,792 | 2028-04-19 | No | 4 | M | Direct | |
| 1,194 | 2028-04-19 | No | 4 | M | Direct | |
| 895 | 2028-04-19 | No | 4 | M | Direct | |
| 1,838 | 2030-04-23 | No | 4 | M | Direct | |
| 1,378 | 2030-04-23 | No | 4 | M | Direct | |
| 918 | 2030-04-23 | No | 4 | M | Direct | |
| 688 | 2030-04-23 | No | 4 | M | Direct | |
| 1,886 | 2029-04-25 | No | 4 | M | Direct | |
| 1,414 | 2029-04-25 | No | 4 | M | Direct | |
| 942 | 2029-04-25 | No | 4 | M | Direct | |
| 707 | 2029-04-25 | No | 4 | M | Direct |
Footnotes
- These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 1, 2024.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.45 to $299.15 as follows: 275 shares sold at $296.45 to $297.41; 888 shares sold at $297.48 to $298.48; and 237 shares sold at $298.50 to $299.15. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.62 to $299.27 as follows: 638 shares sold at $296.62 to $297.49; 1,718 shares sold at $297.68 to $298.67; and 450 shares sold at $298.69 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.28 as follows: 638 shares sold at $296.60 to $297.51; 1,768 shares sold at $297.72 to $298.69; and 400 shares sold at $298.74 to $299.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.27 as follows: 638 shares sold at $296.60 to $297.49; 1,768 shares sold at $297.73 to $298.69; and 400 shares sold at $298.74 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the ReportingPerson's continued service as a director to the issuer.
- Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.
Billionaire Hedge Funds
